These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast. Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, Kasumi F, Sakamoto G. Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781 [Abstract] [Full Text] [Related]
15. Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer. Choi JE, Kang SH, Lee SJ, Bae YK. Ann Surg Oncol; 2015 Jan; 22(1):82-9. PubMed ID: 25145503 [Abstract] [Full Text] [Related]
16. Expression of DNA methylation marker of paired-like homeodomain transcription factor 2 and growth receptors in invasive ductal carcinoma of the breast. Wan Abdul Rahman WF, Fauzi MH, Jaafar H. Asian Pac J Cancer Prev; 2014 Jan; 15(19):8441-5. PubMed ID: 25339043 [Abstract] [Full Text] [Related]
19. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH. Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [Abstract] [Full Text] [Related]
20. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers. Tsang JY, Ni YB, Chan SK, Shao MM, Law BK, Tan PH, Tse GM. Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]